Brief: Theratechnologies Announces Filing Of FDA Prior Approval Supplement For EGRIFTA SV Manufacturing Environment
Dec 18 (Reuters) - Theratechnologies Inc TH.TO :
* THERATECHNOLOGIES ANNOUNCES FILING OF FDA PRIOR APPROVAL
SUPPLEMENT FOR EGRIFTA SV® MANUFACTURING ENVIRONMENT
* THERATECHNOLOGIES: EXISTING INVENTORY LEVELS OF EGRIFTA SV
EXPECTED TO MEET PATIENT DEMAND UNTIL MID-JAN 2025
Source text: ID:nGNX5DpRft
Further company coverage: TH.TO
(((( Reuters.Briefs@thomsonreuters.com ;));))
Recent news on Theratechnologies
See all newsBrief: Theratechnologies Receives Final Court Approval On To Be Acquired By Future Pak
Brief: Theratechnologies Inc - Iss And Glass Lewis Recommend Voting 'For' Future Pak Arrangement
Canadian drugmaker Theratechnologies beats Q2 revenue estimates on strong demand
Brief: Theratechnologies Enters Into Definitive Agreement To Be Acquired By Cb Biotechnology, An Affiliate Of Future Pak
Brief: Theratechnologies Inc Decided To Further Evaluate Potential Sale Of Company Through An Open And Non-Exclusive Process